Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > April Buybacks: Roughly 900K Shares

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon May 10, 2023 8:11am

99 Views

Post# 35440231

RE:April Buybacks: Roughly 900K Shares

And a few more on top of that.
Below 100M shares fairly quickly - IMO.

Filed 2023-05-09 12:46 Tx date 2023-04-30	$GUD Knight Therapeutics Inc.	Knight Therapeutics Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	-796,820 vol	244,800
Filed 2023-05-09 12:33 Tx date 2023-04-28	$GUD Knight Therapeutics Inc.	Knight Therapeutics Inc. 1 - Issuer Direct Ownership	Common Shares 38 - Redemption, retraction, cancellation, repurchase	$899,486 +195,600 vol $4.60 each	1,041,620